IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3510
+0.0324 (10.17%)
At close: Apr 22, 2026, 4:00 PM EDT
0.3500
-0.0010 (-0.28%)
After-hours: Apr 22, 2026, 8:00 PM EDT
IGC Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$5.25
Upside
+1,395.73%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $5.25 | Strong Buy | Maintains | $5 → $5.25 | +1,395.73% | Apr 8, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.75 → $5 | Strong Buy | Maintains | $4.75 → $5 | +1,324.50% | Feb 23, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.5 → $4.75 | Strong Buy | Maintains | $4.5 → $4.75 | +1,253.28% | Dec 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,182.05% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +897.15% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,110.83% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,039.60% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +968.38% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +897.15% | Jul 29, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +897.15% | Jul 17, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $3.25 | Strong Buy | Reiterates | $3.25 | +825.93% | Jun 21, 2024 |